Giovanna Pisi

1.8k total citations
66 papers, 1.1k citations indexed

About

Giovanna Pisi is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Giovanna Pisi has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 8 papers in Infectious Diseases. Recurrent topics in Giovanna Pisi's work include Cystic Fibrosis Research Advances (35 papers), Asthma and respiratory diseases (16 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers). Giovanna Pisi is often cited by papers focused on Cystic Fibrosis Research Advances (35 papers), Asthma and respiratory diseases (16 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers). Giovanna Pisi collaborates with scholars based in Italy, United Kingdom and Russia. Giovanna Pisi's co-authors include Alfredo Chetta, Dario Olivieri, Marina Aiello, Valentina Fainardi, Panagiota Tzani, Andrea Zanini, Susanna Esposito, Margherita Neri, Alberto Argentiero and Angela Battistini and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Journal of Applied Physiology.

In The Last Decade

Giovanna Pisi

64 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giovanna Pisi Italy 20 664 229 128 110 102 66 1.1k
Cristina Bárbara Portugal 17 535 0.8× 337 1.5× 119 0.9× 71 0.6× 57 0.6× 105 1.1k
Cynthia D. Brown United States 14 859 1.3× 463 2.0× 132 1.0× 79 0.7× 79 0.8× 43 1.3k
Eliezer Nussbaum United States 20 741 1.1× 315 1.4× 171 1.3× 127 1.2× 28 0.3× 70 1.3k
Cláudia Henrique da Costa Brazil 17 548 0.8× 329 1.4× 94 0.7× 107 1.0× 33 0.3× 77 967
Paulo José Cauduro Maróstica Brazil 18 781 1.2× 194 0.8× 138 1.1× 123 1.1× 31 0.3× 79 1.1k
Hubertus G.M. Arets Netherlands 21 959 1.4× 543 2.4× 113 0.9× 104 0.9× 32 0.3× 54 1.4k
Ömer Deniz Türkiye 18 393 0.6× 164 0.7× 199 1.6× 217 2.0× 62 0.6× 61 974
Rogério Rufino Brazil 16 501 0.8× 327 1.4× 104 0.8× 94 0.9× 34 0.3× 74 921
Alicia Marín Spain 17 515 0.8× 280 1.2× 158 1.2× 67 0.6× 19 0.2× 50 857
Olivier Le Rouzic France 17 601 0.9× 229 1.0× 93 0.7× 27 0.2× 45 0.4× 62 841

Countries citing papers authored by Giovanna Pisi

Since Specialization
Citations

This map shows the geographic impact of Giovanna Pisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanna Pisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanna Pisi more than expected).

Fields of papers citing papers by Giovanna Pisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanna Pisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanna Pisi. The network helps show where Giovanna Pisi may publish in the future.

Co-authorship network of co-authors of Giovanna Pisi

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanna Pisi. A scholar is included among the top collaborators of Giovanna Pisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanna Pisi. Giovanna Pisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fainardi, Valentina, et al.. (2024). Prevalence of Scoliosis in Children and Adolescents with Cystic Fibrosis. Children. 11(3). 321–321. 1 indexed citations
2.
Fainardi, Valentina, Claudio Sorio, Paola Melotti, et al.. (2024). Elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations. Pediatric Pulmonology. 59(12). 3383–3390. 2 indexed citations
3.
Fainardi, Valentina, Gianluca Milanese, Michela Deolmi, et al.. (2023). Structural changes in lung morphology detected by MRI after modulating therapy with elexacaftor/tezacaftor/ivacaftor in adolescent and adult patients with cystic fibrosis. Respiratory Medicine. 216. 107328–107328. 5 indexed citations
4.
Fainardi, Valentina, et al.. (2023). Nutritional Care in Children with Cystic Fibrosis. Nutrients. 15(3). 479–479. 21 indexed citations
5.
6.
Deolmi, Michela, et al.. (2023). Early Origins of Chronic Obstructive Pulmonary Disease: Prenatal and Early Life Risk Factors. International Journal of Environmental Research and Public Health. 20(3). 2294–2294. 19 indexed citations
7.
Gramegna, Andrea, Stefano Aliberti, Maria Adelaide Calderazzo, et al.. (2023). The impact of elexacaftor/tezacaftor/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: An expert-based Delphi consensus. Respiratory Medicine. 220. 107455–107455. 4 indexed citations
8.
Esposito, Susanna, et al.. (2022). Probiotics Administration in Cystic Fibrosis: What Is the Evidence?. Nutrients. 14(15). 3160–3160. 13 indexed citations
9.
Fainardi, Valentina, Cosimo Neglia, Alberto Argentiero, et al.. (2022). Multidrug-Resistant Bacteria in Children and Adolescents with Cystic Fibrosis. Children. 9(9). 1330–1330. 13 indexed citations
10.
Esposito, Susanna, et al.. (2022). The remaining unsolved problems for rational antibiotic therapy use in pediatric community-acquired pneumonia. Expert Opinion on Pharmacotherapy. 23(4). 497–505. 2 indexed citations
11.
Colombo, Carla, Gianfranco Alicandro, Valeria Daccò, et al.. (2021). SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020. PLoS ONE. 16(5). e0251527–e0251527. 15 indexed citations
12.
Pisi, Roberta, Marina Aiello, Luigino Calzetta, et al.. (2021). Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume. Respiration. 100(5). 404–410. 8 indexed citations
13.
Pisi, Roberta, Marina Aiello, Annalisa Frizzelli, et al.. (2021). Detection of Small Airway Dysfunction in Asymptomatic Smokers with Preserved Spirometry: The Value of the Impulse Oscillometry System. International Journal of COPD. Volume 16. 2585–2590. 16 indexed citations
14.
Fainardi, Valentina, Francesco Longo, Alfredo Chetta, Susanna Esposito, & Giovanna Pisi. (2020). SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew. PubMed Central. 11 indexed citations
15.
Buttini, Francesca, Anna Balducci, Gaia Colombo, et al.. (2018). Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapy. International Journal of Pharmaceutics. 548(1). 182–191. 26 indexed citations
16.
Fainardi, Valentina, et al.. (2014). IOS in school-aged children born preterm: Is small for gestational age a risk factor for small airway dysfunction?. European Respiratory Journal. 44(Suppl 58). P1255–P1255. 1 indexed citations
17.
Casalini, Angelo Gianni, et al.. (2013). Foreign Body Aspiration in Adults and in Children. Journal of Bronchology & Interventional Pulmonology. 20(4). 313–321. 19 indexed citations
18.
Sergio, Francesco, Alfredo Chetta, Giovanna Pisi, Marina Aiello, & Dario Olivieri. (2011). A novel NEXT DPI® dry powder inhaler and its use in asthmatic and COPD population. European Respiratory Journal. 38(Suppl 55). p831–p831. 1 indexed citations
19.
Zompatori, Maurizio, et al.. (2005). Correlation between HRCT and pulmonary functional tests in cystic fibrosis.. PubMed. 110(4). 325–33. 4 indexed citations
20.
Battistini, Angela, et al.. (1997). [Response to bronchodilator administered directly with spray or with spacer].. PubMed. 19(4). 237–42. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Bárbara Breakdown of academic impact, for papers by Cynthia D. Brown Breakdown of academic impact, for papers by Eliezer Nussbaum Breakdown of academic impact, for papers by Cláudia Henrique da Costa Breakdown of academic impact, for papers by Paulo José Cauduro Maróstica Breakdown of academic impact, for papers by Hubertus G.M. Arets Breakdown of academic impact, for papers by Ömer Deniz Breakdown of academic impact, for papers by Rogério Rufino Breakdown of academic impact, for papers by Alicia Marín Breakdown of academic impact, for papers by Olivier Le Rouzic
Rankless by CCL
2026